https://apnews.com/a9c1354c5e60e767539072ade29cfa5a

A rare, rogue immune response is the main suspect as authorities investigate highly unusual blood clots following use of two similar COVID-19 vaccines from Johnson & Johnson and AstraZeneca.

The U.S. recommended that states pause giving the J&J vaccine on Tuesday while authorities examine six reports of the unusual clots, including a death, out of more than 6.8 million Americans given the one-dose vaccination so far.